Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GSK plc (GSK) vs Lumentum (LITE) Price & Performance

Price performance (Past 24H)

Key statistics

GSK plc vs Lumentum — how do they compare? GSK plc trades at $46.82 (market cap $91.88B), while Lumentum trades at $1,118.45 (market cap $94.99B). The key difference: GSK plc and Lumentum are close in size by market cap, and GSK plc pays a 3.9% dividend while Lumentum pays none. Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and Lumentum for 4 Days on average.

GSKLITE
Market Cap
$91.88B$94.99B
Volume
7,730,5294,855,776
Sector
HealthTechnology
52-Week High
$61.18$1.13K
52-Week Low
$43.24$149.61
Typical Hold Time
93 Days4 Days
Enterprise Value
$111.88B$93.92B
Dividend Yield
3.9%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GSK plc

GSK trades at $47.02, up 0.9% today, with a bearish technical signal but strong fundamentals. The company reported revenue of $32.67B in 2025 with a net income margin of 14.52% and has beaten EPS estimates for three consecutive quarters. Recent news highlights strategic oncology investments and a $750M deal for a cancer therapy, signaling growth initiatives.

The outlook is mixed: solid profitability and a reasonable P/E of 15.1 support value, but technical indicators show bearish pressure near key support at $46. Risks include patent expirations and competitive pressures, while analyst sentiment is cautious with 31% buy ratings. Upside depends on pipeline execution and cost savings.

Lumentum

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GSK

No sentiment data available yet.

LITE
100% Buy0% Sell
Avg holding period · 4 Days

Top news

Latest headlines on both assets

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Read more on GSK →

About Lumentum

Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.

Read more on LITE →